title: FDA approved? A critique of the artificial insemination industry in the United States.
abstract: Artificial insemination by donor is becoming an increasingly popular means to achieving parenthood. While the majority of couples use artificial insemination to overcome fertility problems, many recipients use artificial insemination to avoid passing a genetic disease to their children. However, case studies reveal the inherent dangers of artificial insemination, namely the lack of proper screening methods to avoid passing genetic diseases to children born by artificial insemination. State-by-state regulation, federal guidelines, and private adjudication have all proven to be inadequate methods of regulating the artificial insemination industry. Ginsberg proposes federal regulation as the only means of achieving a safe artificial insemination industry. The proposed federal regulation would include better genetic screening, a more efficient national sperm donor system, and limited disclosure to recipients of artificial insemination and their children. These measures would help to ensure that couples using artificial insemination get what they expect--healthy sperm, a safe artificial insemination process, and ultimately, a healthy child.
authors.affiliation: University of Michigan Journal of Law Reform, USA.
authors.forename: K M
authors.initials: KM
authors.lastname: Ginsberg
mesh_terms: D003219:Confidentiality / Q000592:standards; D030881:Disclosure / Q000592:standards; D046148:Donor Selection / Q000331:legislation & jurisprudence / Q000592:standards*; D035082:Federal Government; D005820:Genetic Testing; D033161:Government Regulation; D017408:Guidelines as Topic; D006801:Humans; D007221:Industry / Q000331:legislation & jurisprudence; D007316:Insemination, Artificial, Heterologous / Q000331:legislation & jurisprudence* / Q000592:standards*; D008297:Male; D013074:Sperm Banks / Q000331:legislation & jurisprudence* / Q000592:standards*; D013094:Spermatozoa; D014019:Tissue Donors; D014481:United States